These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 21959323)

  • 1. 24 Versus 48-hour bravo pH monitoring.
    Chander B; Hanley-Williams N; Deng Y; Sheth A
    J Clin Gastroenterol; 2012 Mar; 46(3):197-200. PubMed ID: 21959323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of data obtained from sedated versus unsedated wireless telemetry capsule placement: does sedation affect the results of ambulatory 48-hour pH testing?
    Belafsky PC; Godin DA; Garcia JC; Rahim N
    Laryngoscope; 2005 Jun; 115(6):1109-13. PubMed ID: 15933532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prolonged 48-h wireless capsule esophageal pH monitoring on diagnosis of gastroesophageal reflux disease and evaluation of the relationship between symptoms and reflux episodes.
    Domingues GR; Moraes-Filho JP; Domingues AG
    Arq Gastroenterol; 2011; 48(1):24-9. PubMed ID: 21537538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Catheter-free pH-metry using the Bravo capsule versus standard pH-metry in patients with non-erosive reflux disease (NERD)].
    Mönkemüller K; Neumann H; Fry LC; Kolfenbach S; Malfertheiner P
    Z Gastroenterol; 2009 Apr; 47(4):351-6. PubMed ID: 19358061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oesophageal pH monitoring using the Bravo catheter-free radio capsule.
    Gillies RS; Stratford JM; Booth MI; Dehn TC
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):57-63. PubMed ID: 17206078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years.
    Croffie JM; Fitzgerald JF; Molleston JP; Gupta SK; Corkins MR; Pfefferkorn MD; Lim JR; Steiner SJ; Dadzie SK
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):559-63. PubMed ID: 18030233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference with daily activities and major adverse events during esophageal pH monitoring with bravo wireless capsule versus conventional intranasal catheter: a systematic review of randomized controlled trials.
    Iluyomade A; Olowoyeye A; Fadahunsi O; Thomas L; Libend CN; Ragunathan K; Fenster J; Vignesh S
    Dis Esophagus; 2017 Feb; 30(3):1-9. PubMed ID: 26952638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring.
    Lee YC; Wang HP; Chiu HM; Huang SP; Tu CH; Wu MS; Lin JT
    Gastrointest Endosc; 2005 Dec; 62(6):834-41. PubMed ID: 16301022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of wireless 48-h (Bravo) versus traditional ambulatory 24-h esophageal pH monitoring.
    Håkanson BS; Berggren P; Granqvist S; Ljungqvist O; Thorell A
    Scand J Gastroenterol; 2009; 44(3):276-83. PubMed ID: 19040176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
    Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
    Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy, diagnostic utility and tolerance of intraesophageal pH ambulatory determination with wireless pH-testing monitoring system].
    Carmona-Sánchez R; Solana-Sentíes S
    Rev Gastroenterol Mex; 2004; 69(2):69-75. PubMed ID: 15757154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of prolonged pH measurements on the diagnosis of gastroesophageal reflux disease: 4-day wireless pH studies.
    Scarpulla G; Camilleri S; Galante P; Manganaro M; Fox M
    Am J Gastroenterol; 2007 Dec; 102(12):2642-7. PubMed ID: 17850412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
    Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
    Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial.
    Wenner J; Johnsson F; Johansson J; Oberg S
    Am J Gastroenterol; 2007 Feb; 102(2):239-45. PubMed ID: 17100971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 48-hour wireless oesophageal pH-monitoring in children: are two days better than one?
    Gunnarsdóttir A; Stenström P; Arnbjörnsson E
    Eur J Pediatr Surg; 2007 Dec; 17(6):378-81. PubMed ID: 18072019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.
    Savarino E; Tutuian R; Zentilin P; Dulbecco P; Pohl D; Marabotto E; Parodi A; Sammito G; Gemignani L; Bodini G; Savarino V
    Am J Gastroenterol; 2010 May; 105(5):1053-61. PubMed ID: 19997095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study to compare a symptom-based reflux disease questionnaire to 48-h wireless pH monitoring for the identification of gastroesophageal reflux (revised 2-26-11).
    Lacy BE; Chehade R; Crowell MD
    Am J Gastroenterol; 2011 Sep; 106(9):1604-11. PubMed ID: 21691342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.
    Savarino E; Marabotto E; Zentilin P; Frazzoni M; Sammito G; Bonfanti D; Sconfienza L; Assandri L; Gemignani L; Malesci A; Savarino V
    Dig Liver Dis; 2011 Jul; 43(7):542-7. PubMed ID: 21376679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.